Robert H, a 66-year-old man, is shoveling snow one wintry morning in Minnesota when he slips and falls on a patch of ice. He immediately feels pain in his left hip and is unable to stand. He is brought to the hospital, where x-rays reveal that he has fractured his hip. He undergoes surgery the next day and is discharged to a rehabilitation hospital 3 days later. After less than 24 hours at the rehabilitation hospital, Mr. H develops the sudden onset of pleuritic chest pain. He is brought to the emergency department, where a computed tomography (CT) scan with intravenous contrast reveals a pulmonary embolus. He is treated with heparin and is anticoagulated with warfarin at a starting dose of 5 mg each day, with a target international normalized ratio (INR) of 2.0–3.0. Mr. H is discharged back to his rehabilitation hospital and referred to his local physician. When the INR is subsequently measured, it is 6.2, a value associated with an increased risk of hemorrhage. He is taking no other medication that might interfere with plasma levels of warfarin. The physician advises Mr. H to stop taking warfarin for 2 days. After multiple attempts at adjusting his dose of warfarin, Mr. H eventually reaches a stable INR of 2.5 when taking 1 mg of warfarin each day. What molecular mechanisms could be responsible for the apparent sensitivity of Mr. H to warfarin?
[Expert Solution]: Robert H, a 66-year-old man, is shoveling…
Need help with your Clinical Case Studies case study or NCLEX preparation? Connect with a verified Nursing expert now.